Metastasis and Dehydration

Summary:

Dehydration is found among people with Metastasis, especially for people who are female, 60+ old.

The study analyzes which people have Dehydration with Metastasis. It is created by eHealthMe based on reports of 79 people who have Metastasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Metastasis?

Metastasis (spreadable cancer to other organ from origin) is found to be associated with 536 drugs and 842 conditions by eHealthMe. Check the latest studies of Metastasis.

What is Dehydration?

Dehydration (dryness resulting from the removal of water) is found to be associated with 2,755 drugs and 3,350 conditions by eHealthMe. Check the latest studies of Dehydration.



On Aug, 10, 2026

79 people who have Metastasis and Dehydration are studied.

Would you have Dehydration when you have Metastasis?

Gender of people who have Metastasis and experienced Dehydration *:

  • female: 74.29 %
  • male: 25.71 %

Age of people who have Metastasis and experienced Dehydration *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 2.56 %
  • 20-29: 0.0 %
  • 30-39: 2.56 %
  • 40-49: 2.56 %
  • 50-59: 5.13 %
  • 60+: 87.18 %

Common co-existing conditions for these people *:

  1. Breast Cancer Metastatic: 24 people, 30.38%
  2. Breast Cancer: 7 people, 8.86%
  3. Nausea And Vomiting: 5 people, 6.33%
  4. Bone Pain: 4 people, 5.06%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 5.06%
  6. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 5.06%
  7. Renal Cell Carcinoma (a kidney cancer): 4 people, 5.06%
  8. Neoplasm Malignant (cancer tumour): 3 people, 3.80%
  9. Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 3 people, 3.80%
  10. Metastases To Liver (cancer spreads to liver): 2 people, 2.53%

Common drugs taken by these people *:

  1. Zoledronic Acid: 30 people, 37.97%
  2. Kisqali: 27 people, 34.18%
  3. Xgeva: 26 people, 32.91%
  4. Anastrozole: 24 people, 30.38%
  5. Amlodipine Besylate: 14 people, 17.72%
  6. Metformin: 12 people, 15.19%
  7. Glimepiride: 12 people, 15.19%
  8. Zofran: 10 people, 12.66%
  9. Carboplatin: 7 people, 8.86%
  10. Cabometyx: 7 people, 8.86%

Common symptoms for these people *:

  1. Renal Impairment (severely reduced kidney function): 30 people, 37.97%
  2. Diarrhea: 25 people, 31.65%
  3. Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 25 people, 31.65%
  4. Nausea (feeling of having an urge to vomit): 20 people, 25.32%
  5. Nausea And Vomiting: 20 people, 25.32%
  6. Anaemia (lack of blood): 20 people, 25.32%
  7. Fatigue (feeling of tiredness): 15 people, 18.99%
  8. Acute Kidney Failure: 14 people, 17.72%
  9. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 10 people, 12.66%
  10. Weakness: 9 people, 11.39%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Dehydration?

- Check whether Dehydration is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Dehydration:

All the conditions that are associated with Dehydration:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Dehydration and Metastasis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: